{"id":"https://openalex.org/W2601965721","doi":"https://doi.org/10.1200/jco.2017.35.6_suppl.335","title":"A chemically-modified miR-21 inhibitor (ADM-21) as a novel potential therapy in bladder cancer.","display_name":"A chemically-modified miR-21 inhibitor (ADM-21) as a novel potential therapy in bladder cancer.","publication_year":2017,"publication_date":"2017-02-20","ids":{"openalex":"https://openalex.org/W2601965721","doi":"https://doi.org/10.1200/jco.2017.35.6_suppl.335","mag":"2601965721"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2017.35.6_suppl.335","doi":"https://doi.org/10.1200/jco.2017.35.6_suppl.335","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.6_suppl.335","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049657362","display_name":"Alexandra Drakaki","orcid":"https://orcid.org/0000-0001-8865-3548","observed_orcids":["https://orcid.org/0000-0001-8865-3548"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Drakaki","raw_affiliation_strings":["Department of Medicine, University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069224672","display_name":"\u039c\u03b1\u03c1\u03af\u03bd\u03b1 \u039a\u03bf\u03c5\u03c4\u03c3\u03b9\u03bf\u03cd\u03bc\u03c0\u03b1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Koutsioumpa","raw_affiliation_strings":["UCLA, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028010756","display_name":"Neil A. O\u2019Brien","orcid":"https://orcid.org/0000-0001-7408-1091","observed_orcids":["https://orcid.org/0000-0001-7408-1091"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil A. O'Brien","raw_affiliation_strings":["School of Medicine/Translational Oncology Research Laboratory, University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine/Translational Oncology Research Laboratory, University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004609678","display_name":"Christina Vorvis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Vorvis","raw_affiliation_strings":["Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Systems Biomedicine, Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064972382","display_name":"Dimitrios Iliopoulos","orcid":"https://orcid.org/0000-0003-2780-2372","observed_orcids":["https://orcid.org/0000-0003-2780-2372"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dimitrios Iliopoulos","raw_affiliation_strings":["Center of Systems Biomedicine, Division of Digestive Disease, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Systems Biomedicine, Division of Digestive Disease, Los Angeles, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA;","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"6_suppl","first_page":"335","last_page":"335"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mir-21","display_name":"miR-21","score":0.9049999713897705},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.6489999890327454},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.7390000224113464},{"id":"https://openalex.org/keywords/phosphorothioate-backbone","display_name":"phosphorothioate backbone","score":0.7670000195503235},{"id":"https://openalex.org/keywords/locked-nucleic-acid","display_name":"locked nucleic acid","score":0.9110000133514404},{"id":"https://openalex.org/keywords/mirna-inhibitors","display_name":"miRNA inhibitors","score":0.7820000052452087},{"id":"https://openalex.org/keywords/ppp2r2a","display_name":"PPP2R2A","score":0.984000027179718},{"id":"https://openalex.org/keywords/akt-mtor-signaling-pathway","display_name":"Akt/mTOR signaling","score":0.9120000004768372},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.5649999976158142},{"id":"https://openalex.org/keywords/tumor-suppressor-genes","display_name":"tumor suppressor","score":0.7409999966621399},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.6600000262260437},{"id":"https://openalex.org/keywords/chemically-modified-oligonucleotides","display_name":"modified oligonucleotides","score":0.5690000057220459},{"id":"https://openalex.org/keywords/oncogenic-microrna","display_name":"oncogenic microRNA","score":0.5329999923706055},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.5529999732971191},{"id":"https://openalex.org/keywords/drug-delivery-routes","display_name":"drug delivery routes","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.8234263062477112},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6642616987228394},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.6415638327598572},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.5613702535629272},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5350331664085388},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5125019550323486},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4943718910217285},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4585338532924652},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4512379467487335},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4452091455459595},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4261574149131775},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.3622993528842926},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.31174153089523315},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.2919055223464966},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28573092818260193},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19699391722679138},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1607791781425476},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1595960259437561},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2017.35.6_suppl.335","doi":"https://doi.org/10.1200/jco.2017.35.6_suppl.335","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2017.35.6_suppl.335","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2497779620","https://openalex.org/W2800964938","https://openalex.org/W2316603856","https://openalex.org/W2018088692","https://openalex.org/W2096088479","https://openalex.org/W3006071965","https://openalex.org/W4393130828","https://openalex.org/W2149767054","https://openalex.org/W3021677410","https://openalex.org/W3083899576"],"abstract_inverted_index":{"335":[0],"Background:":[1],"MicroRNAs":[2],"are":[3],"key":[4],"regulators":[5],"of":[6,37,54,64,94,186,201,210,225,243,248,257,282,298],"cancer":[7,57,67,130,204,289],"signaling":[8],"pathways.Targeting":[9],"their":[10],"expression":[11,46],"has":[12],"therapeutic":[13,35],"potential.":[14],"MicroRNA-21":[15],"(miR-21)":[16],"acts":[17],"as":[18],"an":[19],"oncogene":[20],"in":[21,30,51,99,102,110,120,135,170,220,291,294],"several":[22],"cancers.":[23,127],"Here":[24],"we":[25,305],"describe":[26],"its":[27],"functional":[28],"significance":[29],"bladder":[31,56,66,111,126,171,203,259,288,314],"oncogenesis":[32],"and":[33,59,82,91,101,117,182,197,236,250,261,280,293,302],"the":[34,187,195,199,240,283],"properties":[36,169],"a":[38,52,78,148,176,183,265,276],"novel":[39,177,266],"chemically-modified":[40,79],"miR-21":[41,87,143,155,178,272,277],"inhibitor":[42],"(ADM-21).":[43],"Methods:":[44],"MiR-21":[45,105],"was":[47,97,106,212],"assessed":[48],"by":[49,108,118],"RT-PCR":[50],"panel":[53],"human":[55,258],"tissues":[58],"cell":[60,68,131,262],"lines.":[61],"Transcriptomic":[62,145],"profiling":[63],"28":[65,129],"lines":[69,132,263],"performed":[70],"to":[71,114,123,142],"identify":[72],"miR-21-dependent":[73],"gene":[74,181],"signatures.":[75],"ADM-21":[76,95,190,211,226,299],"is":[77,275],"(phosphorothioate":[80],"backbone":[81],"locked-nuclei-acid)":[83],"antisense":[84],"oligo":[85],"against":[86],"with":[88,154,271],"high":[89],"potency":[90],"stability.The":[92],"efficacy":[93],"treatment":[96,192],"evaluated":[98],"vitro":[100,292],"vivo.":[103,295],"Results:":[104],"up-regulated":[107],"5-fold":[109],"tumors":[112,244,260],"relatively":[113],"normal":[115],"tissue":[116],"3-fold":[119],"advanced":[121,313],"compared":[122],"early":[124],"stage":[125],"The":[128],"were":[133],"stratified":[134],"3":[136,232],"groups":[137],"(high,":[138],"intermediate,":[139],"low)":[140],"according":[141],"levels.":[144,156,273],"analysis":[146,256],"revealed":[147,264],"15-gene":[149,267],"signature":[150,268],"that":[151,269],"negatively":[152],"correlated":[153],"Protein":[157],"Phosphatase":[158],"2":[159],"Regulatory":[160],"Subunit":[161],"B":[162],"Isoform":[163],"A":[164],"(PPP2R2A)":[165],"displayed":[166],"tumor":[167],"suppressive":[168],"cancer.":[172,315],"Moreover,":[173],"PPP2R2A":[174,274],"represents":[175],"direct":[179,278],"target":[180,279],"negative":[184],"regulator":[185,281],"AKT/mTOR":[188,284],"pathway.":[189,285],"(10uM)":[191],"suppressed":[193],"43.5%":[194],"growth":[196,241,290],"90%":[198],"invasiveness":[200],"5367":[202,249],"cells.":[205],"Also,":[206],"intravenous":[207],"(I.V.)":[208,227],"administration":[209,219],"proven":[213],"more":[214],"effective":[215],"than":[216],"intraperitoneal":[217],"(I.P.)":[218],"mouse":[221],"xenografts.":[222],"Specifically,":[223],"15mg/kg":[224],"every":[228],"5":[229],"days":[230],"for":[231,312],"cycles":[233],"reduced":[234],"37%":[235],"47%":[237],"(day":[238],"16)":[239],"rate":[242],"originating":[245],"from":[246],"injections":[247],"RT-112":[251],"cells,":[252],"respectively.":[253],"Conclusions:":[254],"Integrative":[255],"correlates":[270],"ADM-21effectively":[286],"reduces":[287],"Upon":[296],"completion":[297],"toxicology":[300],"studies":[301],"confirm":[303],"safety":[304],"will":[306],"design":[307],"phase":[308],"I":[309],"clinical":[310],"trial":[311]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2017-04-07T00:00:00"}